Total trials
93
Active
29
Phase 3
18
Total enrollment
76,220
Pipeline matrix
Showing 25 of 25 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| N-acetyl cysteine | — | — | — | — | — | 1 | |
| Enzalutamide | — | — | — | — | — | 2 | |
| Fenofibrate | — | — | — | — | — | 1 | |
| Inert lactose placebo | — | — | — | — | — | 1 | |
| Tenecteplase | — | — | — | — | — | 1 | |
| Vitamin K1 | — | — | — | — | — | 1 | |
| Magnesium citrate | — | — | — | — | — | 1 | |
| Sodium Thiosulfate | — | — | — | — | — | 1 | |
| Methylprednisolone | — | — | — | — | — | 1 | |
| Prednisone | — | — | — | — | — | 1 | |
| Fosfomycin | — | — | — | — | — | 1 | |
| Standard of care antibiotics | — | — | — | — | — | 1 | |
| Conventional NSAA | — | — | — | — | — | 1 | |
| LHRHA | — | — | — | — | — | 1 | |
| Bleomycin | — | — | — | — | — | 1 | |
| Etoposide | — | — | — | — | — | 1 | |
| Cisplatin | — | — | — | — | — | 1 | |
| Pegylated G-CSF | — | — | — | — | — | 1 | |
| Filgrastim | — | — | — | — | — | 1 | |
| Darolutamide | — | — | — | — | — | 1 | |
| Luteinizing Hormone-Releasing Hormone Analog | — | — | — | — | — | 1 | |
| NSAA | — | — | — | — | — | 1 | |
| LHRHA or Surgical Castration | — | — | — | — | — | 1 | |
| Nivolumab | — | — | — | — | — | 1 | |
| Temozolomide | — | — | — | — | — | 1 |
Next readouts
- 2024-06-28
- 2024-12-31
- 2025-11
- 2026-06
- 2026-08-28
- 2026-12-31
- 2027-08
- 2028-01-31
- 2029-12
- 2029-12-31
Top conditions
- Lung Cancer5
- Diabetic Macular Oedema5
- Obesity4
- Diabetic Retinopathy4
- Cancer4
- Stroke3
- Stuttering2
- Radiation Therapy Complication2
Frequently asked questions about University of Sydney
- How many clinical trials does University of Sydney have on ClinicalTrials.gov?
- University of Sydney is listed as the lead sponsor on 93 clinical trials in ClinicalTrials.gov, 29 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Sydney's trials are in Phase 3?
- 18 of University of Sydney's trials are in Phase 3, spread across 25 active drug programs.
- What therapeutic areas does University of Sydney focus on?
- University of Sydney's most-studied conditions on ClinicalTrials.gov are Lung Cancer, Diabetic Macular Oedema, Obesity, Diabetic Retinopathy, Cancer.
- When are University of Sydney's next clinical trial readouts?
- University of Sydney has 10 upcoming primary-completion readouts tracked here; the soonest is “Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM”, expected around 2024-06-28.